The Hypertrophic Cardiomyopathy Medical Society (HCMS) focuses on enhancing the understanding and treatment of hypertrophic cardiomyopathy (HCM) through collaboration among healthcare professionals. HCMS seeks to foster research and clinical practices that lead to improved patient outcomes and education about HCM.
2021
87-2235662
$292.1 thousand
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
A community of dedicated professionals focused on hypertrophic cardiomyopathy.
Providing essential education and research on hypertrophic cardiomyopathy.
Annual events gathering experts to discuss advancements in HCM.
Overall Score
46
34
/100
Program Expense Ratio
82.38%
14
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0
2
/20
Working Capital Ratio
2.123
14
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 448.3K | 99.39% |
Program Services | 2.759K | 0.61% |
Investment Income | 0 | 0.00% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 451.1K | 100.00% |
Health Care
Health Care AssociationHealth Care
Health Care AssociationHealth Care
Health Care AssociationHealth Care
Health Care AssociationHealth Care
Health Care Association